Revumenib (SNDX-5613)
Menin Inhibitor
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)
Axatilimab (SNDX-6352)
CSF-1R mAB
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)
Entinostat (SNDX-275)
Class 1 HDAC Inhibitor
PreClin
Phase 1
Phase 2
Pivotal
Indication(s)
Revumenib (SNDX-5613)
Menin Inhibitor
Axatilimab (SNDX-6352)
CSF-1R mAB
Entinostat (SNDX-275)
Class 1 HDAC Inhibitor